Open access
168
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Report
Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study
Tanja Plate1 AstraZeneca GmbH, Wedel, Germanyhttps://orcid.org/0000-0001-8697-6458
, Felix W Friedrich1 AstraZeneca GmbH, Wedel, GermanyCorrespondence[email protected]
& Jutta Beier2 Insaf - Respiratory Research Institute GmbH, Wiesbaden, Germanyhttps://orcid.org/0000-0002-8254-7936
Pages 1335-1347
|
Published online: 10 Jun 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.